United States· US:57664-088_0b77417a-5789-8818-e063-6294a90ad2e3
LISDEXAMFETAMINE DIMESYLATE
A lisdexamfetamine product containing lisdexamfetamine dimesylate, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lisdexamfetamine is registered in 15 of 19 countries.
Countries holding a registration under ATC N06BA12 (lisdexamfetamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Lisdexamfetamine · ATC N06BA12
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lisdexamfetamine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lisdexamfetamine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.28
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- N06BA12
- ATC class
- Lisdexamfetamine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 2, 2026
Packs & prices · 2
- ndc1157664-088-88
- ndc115766408888100 TABLET, CHEWABLE in 1 BOTTLE (57664-088-88)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for lisdexamfetamine.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lisdexamfetamine · interactions on record
217 records
- 51 severe
- 164 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lisdexamfetamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaTARO-LISDEXAMFETAMINE CHEWABLE TABLETSTARO PHARMACEUTICALS INC
- SwedenAdixemin 20 mg Kapsel, hårdSTADA Arzneimittel AG
- FinlandAdixeminSTADA Arzneimittel AG
- NorwayAduvanz2care4 ApS
- IcelandAdixeminSTADA Arzneimittel AG
- United KingdomElvanse 20mg capsulesTakeda UK Ltd
- PolandEldefabG.L. Pharma GmbH
- IrelandLisdexamfetamine dimesylate Rowex 20 mg hard capsulesRowex Limited,
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Elvanse, Elvanse Erwachsene
- Belgium · Elvanse
- Czechia · Livizux
- Germany · Elvanse, Lisdex- Aristo
- Denmark · Adixemin, Aduvanz
- Estonia · Adixemin, Elvanse
- Spain · Elvanse, Elvanse Adultos
- Finland · Dexhility, Elvanse
- France · Fobettin, Xurta
- United Kingdom (Northern Ireland) · Elvanse, Elvanse Adult
- Hungary · Livizux
- Ireland · Lisdexamfetamine Dimesylate Rowex, Tyvense
- Iceland · Amdex, Dexhility
- Italy · Minalix
- Lithuania · Adixemin
- Luxembourg · Elvanse
- Latvia · Adixemin, Lisdexamfetamine Zentiva
- Malta · Lisdexamfetamin, Lisdexamfetamine Aristo Aristo
- Netherlands · Elvanse, Lisdexamfetamine Aristo Aristo
- Norway · Aduvanz, Balidax
- Poland · Eldefab, Elvanse
- Portugal · Dimesilato De Lisdexanfetamina Teva, Dimesilato De Lisdexanfetamina Zentiva
- Romania · Lisdexamfetaminä Stada
- Sweden · Balidax, Dexhility
- Slovenia · Lisdeksamfetamin Aristo, Lisdeksamfetamin Aristo Aristo
- Slovakia · Livizux
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/beb62c92-0464-4199-9165-1aa00b1a1ede GET /v1/drugs/beb62c92-0464-4199-9165-1aa00b1a1ede?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "60",
"substance": "LISDEXAMFETAMINE DIMESYLATE",
"productndc": "57664-088",
"dosage_form": "TABLET, CHEWABLE",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "ANDA214134",
"marketing_category": "ANDA"
}See everything about lisdexamfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.